Evidence map›Paper›PMID 42654029›Full record

ArticlePharmaceutics2026

Ion- and pH-Responsive In Situ Gel Incorporating Luteolin-Loaded Nanostructured Lipid Carriers Enhances Ocular Bioavailability and Anti-Angiogenic Efficacy for Corneal Neovascularization.

Yinjian Ji, Zhen Liang, Jingjing Yang, Guojuan Pu, Xue He, Ming Jiang, Tao Wu, Junjie Zhang, Tianyang Zhou, Yuwei Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yinjian JiDepartment of the First Clinical Medicine, Henan University of Chinese Medicine, Zhengzhou 450003, China.ORCID 0009-0003-3373-9864
Zhen LiangHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
Jingjing YangHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
Guojuan PuHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
Xue HeDepartment of the First Clinical Medicine, Henan University of Chinese Medicine, Zhengzhou 450003, China.
Ming JiangDepartment of the First Clinical Medicine, Henan University of Chinese Medicine, Zhengzhou 450003, China.
Tao WuDepartment of the First Clinical Medicine, Henan University of Chinese Medicine, Zhengzhou 450003, China.
Junjie ZhangHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
Tianyang ZhouHenan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China.
Yuwei WangDepartment of the First Clinical Medicine, Henan University of Chinese Medicine, Zhengzhou 450003, China.

Funding

2025 Annual Key Discipline Construction Project-New Round of Provincial Key Disciplines-Clinical Medicine 15102040X-3-2Henan Eye Hospital Basic Science Research Program 25JCQN009Major Science and Technology Special Project of Henan Province 251100110200Natural Science Foundation of Henan Province 252300423780Natural Science Foundation of Henan Province 252300423781
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

corneal neovascularizationenhance ocular bioavailabilityin situ gelion- and pH-responsiveluteolin

Identifiers

PMID42654029
PMCPMC13517062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.